Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00078338
Status:
COMPLETED
Last Update Posted:
2018-06-27
First Post:
2004-02-23
Brief Title:
Rebif Versus Copaxone in the Treatment of Relapsing Remitting Multiple Sclerosis
Sponsor:
EMD Serono
Organization:
EMD Serono
Organization Data
Organization:
EMD Serono
Class:
INDUSTRY
Study ID:
24735
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
EMD Serono
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |